HS OBTAIN
App for assessing the efficacy and safety of SAR442970 in moderate to severe HS.
Developer: THREAD
App Size: Varies With Device
Release Date: Oct 2, 2023
Price: Free
Medical
HS OBTAIN
Screenshots for App
Mobile
Your app for the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.
More Information about: HS OBTAIN
Price:
Free
Version:
1.0.69
Downloads:
14
Compatibility:
Android 5.0
Bundle Id:
com.thread.t7c806f7
Size:
Varies With Device
Last Update:
2023-10-10
Content Rating:
Everyone
Release Date:
Oct 2, 2023
Content Rating:
Everyone
Developer:
THREAD
Latest Apps & Games
